Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Sichuan Haisco Invests $6 Million in eXithera, Gains China Rights to Novel Anti-Coagulant

publication date: Apr 1, 2019

Sichuan Haisco Pharma will invest $6 million in eXithera, a US biopharma developing a novel anti-coagulant, and will own China rights to the product. Haisco will be responsible for development, trials, registration and production in China, and it will pay eXithera royalties on any future sales. After the financing, Haisco will own 12.5% of eXithera, a portfolio company of Israel's Clal Biotechnology Industries. Haisco has previously invested in several Israeli medical device companies, including Endospan, MST and Sensible. More details....

Stock Symbol: (SZE: 002653)

Share this with colleagues:


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here

BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here

Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here